Search Within

Ghassan Abou-Alfa

Formats
  1. Meeting Abstract (268)
  2. Journal Article (247)
  3. Review (27)
  4. Book Section (16)
  5. Editorial (8)
  6. Book Whole (4)
  7. Correspondence (4)
  8. Guidelines (4)
  9. Miscellaneous (3)
  10. Research Letter (1)
Groups
  1. Department of Medicine (582)
  2. Gastrointestinal Oncology Service (582)
  3. Solid Tumor Oncology Division (582)
  4. Center for Pancreatic Cancer Research (218)
  5. Epidemiology and Biostatistics (124)
  6. Surgery (103)

More Groups

People
  1. Eileen O'Reilly (159)
  2. James Harding (134)
  3. Marinela Capanu (67)
  4. William Jarnagin (66)
  5. Leonard Saltz (55)
  6. Imane El Dika (54)

More People

Years
  1. 2025 (27)
  2. 2024 (52)
  3. 2023 (48)
  4. 2022 (53)
  5. 2021 (46)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (167)
  2. Annals of Oncology (57)
  3. Gastrointestinal Cancer Research (21)
  4. Oncology Research and Treatment (18)
  5. Annals of Surgical Oncology (15)
  6. Cancer (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (183)
  2. Oxford University Press (69)
  3. Springer (36)
  4. Wiley Blackwell (30)
  5. Elsevier Inc. (25)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (582)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy
    Meeting Abstract

    Keane, F.; Cowzer, D.; Khalil, D.; Shia, J.; Do, R.; Folorunso, S.; El Dika, I.; Yaqubie, A.; Kim, T.; O'Reilly, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Modeling of proliferating CD4 and CD8 T-cell changes to tremelimumab exposure in patients with unresectable hepatocellular carcinoma
    Journal Article

    Song, X.; Kelley, R. K.; Green, M.; Standifer, N.; Lim, K.; Zhou, D.; Dunyak, J.; Negro, A.; Kurland, J. F.; Ren, S.; more...
    Clinical Pharmacology & Therapeutics (2023)

    Fulltext@MSK | Save
  • Autologous cytotoxic T-cell receptor T cell therapy (SCG101) against hepatitis B surface antigen phase I/II trial for patients with advanced hepatitis B-related hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Yong, W. P.; Chang, S. L.; Fan, J.; Toh, H. C.; Yau, T.; Choo, S.; Wang, J.; Kusuma, N.; Ma, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Temporal patterns of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Lau, G.; Sangro, B.; Crysler, O. V.; Sukeepaisarnjaroen, W.; Lipatov, O.; Morimoto, Ma.; Archambeaud, I.; Burgio, V.; Tuyet Phuong, L. T.; Chao, Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Lau, G.; Cheng, A. L.; Sangro, B.; Kudo, M.; Kelley, R. K.; Tak, W. Y.; Gasbarrini, A.; Reig, M.; Lim, H. Y.; Tougeron, D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers
    Meeting Abstract

    Balogun, F.; Altoe, M.; O'Connor, C.; Chowdhury, N.; Cercek, A.; Lee, C. K.; Foote, M. B.; Kim, D.; Maron, S. B.; Kim, D. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
    Review

    Costa, F.; Wiedenmann, B.; Roderburg, C.; Mohr, R.; Abou-Alfa, G. K.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Low-energy amplitude-modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma
    Journal Article

    Capareli, F.; Costa, F.; Tuszynski, J. A.; Sousa, M. C.; Setogute, Y. D. C.; Lima, P. D.; Carvalho, L.; Santos, E.; Gumz, B. P.; Sabbaga, J.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Association between posttreatment α-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Wang, X.; Parrinello, C. M.; Gossai, A.; Kim, R.; Magee, K.; Miksad, R. A.
    Cancer (2023)

    Fulltext@MSK | Save